Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Hauser

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
NPJ Parkinson'S Disease|April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's diseaseAndrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profilesStefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 13, 2019
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profileStefanie Lerche, Gerrit Machetanz, Isabel Wurster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2021
A Novel SNCA A30G Mutation Causes Familial Parkinson's DiseaseHui Liu, Christos Koros, Timo Strohäker, et al.
Acta Neuropathologica Communications|October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodiesKathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
European Journal of Neurology|January 29, 2025
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's diseaseIoanna Alefanti, Christos Koros, Viktoria Tsami, et al.
Neurology|October 23, 2020
Phenylalanine Effects on Brain Function in Adult PhenylketonuriaAndrea Pilotto, Carl M Zipser, Edytha Leks, et al.
Brain : a Journal of Neurology|April 17, 2026
Blood mtDNA markers of mitochondrial subtype and early-onset Parkinson's disease biologyAnne Grünewald, Felix Knab, Milan Zimmermann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 6, 2023
Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's DiseaseChristos Koros, Kathrin Brockmann, Athina-Maria Simitsi, et al.
Brain : a Journal of Neurology|October 21, 2017
Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's diseaseJulia C Fitzgerald, Alexander Zimprich, Daniel A Carvajal Berrio, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|April 14, 2026
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson's diseaseAndrea Mastrangelo, Isabel Wurster, Alice Ticca, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profilesStefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 13, 2019
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profileStefanie Lerche, Gerrit Machetanz, Isabel Wurster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2021
A Novel SNCA A30G Mutation Causes Familial Parkinson's DiseaseHui Liu, Christos Koros, Timo Strohäker, et al.
Acta Neuropathologica Communications|October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodiesKathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
European Journal of Neurology|January 29, 2025
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's diseaseIoanna Alefanti, Christos Koros, Viktoria Tsami, et al.
Neurology|October 23, 2020
Phenylalanine Effects on Brain Function in Adult PhenylketonuriaAndrea Pilotto, Carl M Zipser, Edytha Leks, et al.
Brain : a Journal of Neurology|April 17, 2026
Blood mtDNA markers of mitochondrial subtype and early-onset Parkinson's disease biologyAnne Grünewald, Felix Knab, Milan Zimmermann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 6, 2023
Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's DiseaseChristos Koros, Kathrin Brockmann, Athina-Maria Simitsi, et al.
Brain : a Journal of Neurology|October 21, 2017
Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's diseaseJulia C Fitzgerald, Alexander Zimprich, Daniel A Carvajal Berrio, et al.
Pageof 6